FILANA THERAPEUTICS, INC. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-K405
10-Q
144
25-NSE
3
4
4/A
424B1
424B2
424B3
424B5
5
8-A12B
8-A12G
8-A12G/A
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
EFFECT
FWP
PRE 14A
RW
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | FORM 10-K | 0001437749-26-007962 | Mar 12, 2026 | Dec 31, 2025 |
| 8-K | FORM 8-K | 0001171843-26-001506 | Mar 12, 2026 | — |
| 8-K | FORM 8-K | 0001437749-26-007422 | Mar 10, 2026 | — |
| 8-K | FORM 8-K | 0001171843-26-000922 | Feb 19, 2026 | — |
| 8-K | FORM 8-K | 0001437749-25-038605 | Dec 23, 2025 | Dec 19, 2025 |
| 8-K/A | FORM 8-K/A | 0001437749-25-038544 | Dec 22, 2025 | Oct 21, 2025 |
| 8-K | FORM 8-K | 0001437749-25-038313 | Dec 18, 2025 | Dec 15, 2025 |
| 8-K | FORM 8-K | 0001437749-25-038157 | Dec 17, 2025 | Dec 12, 2025 |
| EFFECT | — | 9999999995-25-003554 | Dec 5, 2025 | — |
| 424B2 | 424B2 | 0001493152-25-026408 | Dec 5, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-036710 | Dec 3, 2025 | Nov 26, 2025 |
| 4 | FORM 4 | 0001437749-25-036321 | Nov 25, 2025 | Nov 24, 2025 |
| 4 | FORM 4 | 0001437749-25-036125 | Nov 24, 2025 | Nov 20, 2025 |
| 4 | FORM 4 | 0001437749-25-035882 | Nov 20, 2025 | Nov 19, 2025 |
| S-3 | S-3 | 0001493152-25-022066 | Nov 13, 2025 | — |
| 10-Q | FORM 10-Q | 0001437749-25-034427 | Nov 12, 2025 | Sep 30, 2025 |
| 8-K | FORM 8-K | 0001171843-25-007222 | Nov 12, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-031674 | Oct 24, 2025 | Oct 23, 2025 |
| 4 | FORM 4 | 0001437749-25-031540 | Oct 22, 2025 | Oct 21, 2025 |
| 3 | FORM 3 | 0001437749-25-031538 | Oct 22, 2025 | Oct 21, 2025 |
| 8-K | FORM 8-K | 0001437749-25-031466 | Oct 22, 2025 | Oct 21, 2025 |
| 4 | FORM 4 | 0001437749-25-030348 | Oct 2, 2025 | Sep 30, 2025 |
| 4 | FORM 4 | 0001437749-25-029725 | Sep 23, 2025 | Sep 22, 2025 |
| 4 | FORM 4 | 0001437749-25-029586 | Sep 22, 2025 | Sep 18, 2025 |
| 8-K | FORM 8-K | 0001437749-25-028530 | Sep 8, 2025 | — |
| 10-Q | FORM 10-Q | 0001437749-25-026686 | Aug 14, 2025 | Jun 30, 2025 |
| 8-K | FORM 8-K | 0001171843-25-005406 | Aug 14, 2025 | — |
| 8-K | FORM 8-K | 0001171843-25-004981 | Aug 4, 2025 | — |
| SCHEDULE 13G/A | — | 0000932471-25-000781 | Jul 29, 2025 | — |
| 4 | FORM 4 | 0001437749-25-022829 | Jul 16, 2025 | May 23, 2025 |
| SCHEDULE 13G/A | — | 0002052113-25-002493 | Jul 16, 2025 | — |
| 8-K | FORM 8-K | 0001171843-25-004211 | Jun 30, 2025 | — |
| 4 | FORM 4 | 0001437749-25-018505 | May 27, 2025 | May 23, 2025 |
| 4 | FORM 4 | 0001437749-25-018503 | May 27, 2025 | May 23, 2025 |
| 4 | FORM 4 | 0001437749-25-018500 | May 27, 2025 | May 23, 2025 |
| 4 | FORM 4 | 0001437749-25-018497 | May 27, 2025 | May 23, 2025 |
| 4 | FORM 4 | 0001437749-25-018494 | May 27, 2025 | May 23, 2025 |
| 8-K | FORM 8-K | 0001437749-25-018482 | May 27, 2025 | May 23, 2025 |
| 10-Q | FORM 10-Q | 0001437749-25-015478 | May 8, 2025 | Mar 31, 2025 |
| 8-K | FORM 8-K | 0001171843-25-002954 | May 8, 2025 | — |
| 4 | FORM 4 | 0001437749-25-012557 | Apr 21, 2025 | Apr 17, 2025 |
| 4 | FORM 4 | 0001437749-25-012554 | Apr 21, 2025 | Apr 17, 2025 |
| 4 | FORM 4 | 0001437749-25-012549 | Apr 21, 2025 | Apr 17, 2025 |
| 4 | FORM 4 | 0001437749-25-012545 | Apr 21, 2025 | Apr 17, 2025 |
| 8-K | FORM 8-K | 0001437749-25-012540 | Apr 21, 2025 | Apr 15, 2025 |
| ARS | ARS | 0001437749-25-011856 | Apr 14, 2025 | Dec 31, 2024 |
| DEF 14A | FORM DEF 14A | 0001437749-25-011848 | Apr 14, 2025 | May 23, 2025 |
| PRE 14A | FORM PRE 14A | 0001437749-25-010891 | Apr 3, 2025 | May 23, 2025 |
| 8-K | FORM 8-K | 0001171843-25-001678 | Mar 25, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-007019 | Mar 11, 2025 | Mar 6, 2025 |